Ann: ATL1102 for DMD EMA PIP feedback and FDA regulatory progress, page-48

Wayne,

History says Scrooge McDuck gets involved after a successful P2....it's the sweet spot for all Biotech M&A activity.

Really depends which Pekin Scrooge McDuck takes an interest?

The America McDuck is in a world of pain with their Gene Therapy is the poop. They need a plan B.

The Swiss McDuck invested all their $1.3B duck eggs into The American McDuck's GT program.

Then there is the German McDuck - they too are in the middle of Gene Therapy, BUT the FDA has put a hold on their trial in the US.

And then....long shot....the CSL connections: Moses, Dr Gittleson etc.

Could CSL play a role here under the licensing model?

Exciting times ahead.

.